Medtronic (MDT) Q1 2025 10-Q Quarterly Report
Filed: Feb 25, 2025Period ending Jan 24, 2025
Health Care
Electromedical & Electrotherapeutic ApparatusSEC EDGAR Medtronic (MDT) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on Feb 25, 2025 for the fiscal period ending Jan 24, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Medtronic Q1 2025 10-Q Analysis
Risk Factors
- • No newly added risk factors this quarter; risk section largely unchanged from the prior 10-K
- • Pricing pressure risk updated with increased emphasis on decreasing selling prices impacting margins
Medtronic Q1 2025 Quarterly FinancialsXBRL
Revenue
$8.3B
▲ +2.5% YoY▼ -1.3% QoQ
Net Income
$1.3B
▼ -2.1% YoY▲ +1.9% QoQ
Operating Margin
19.9%
▲ +152bp YoY▲ +87bp QoQ
Net Margin
15.6%
▼ -74bp YoY▲ +49bp QoQ
EPS (Diluted)
$1.00
▲ +1.0% YoY▲ +1.0% QoQ
Operating Cash Flow
$2.6B
▲ +4.0% YoY▲ +168.5% QoQ
Source: XBRL data from Medtronic Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Medtronic Quarterly Reports
Get deeper insights on Medtronic
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.